If gay men can avoid HIV with a pill, why aren’t they taking it?
Early study results on the effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV transmission are promising, but gay men are not rushing to take the drug. Why not?
In the fourth part of Daily Xtra’s four-part series, Nicolas Kazamia investigates why so few gay men are embracing the promise of PrEP. Interviewees include Robert Grant, a senior researcher at the Gladstone Institutes; HIV/AIDS prevention workers Tim Ryan and Steve Gibson, from Magnet, a sexual health clinic in San Francisco; and Alan McCord, from Project Inform.
In the series:
Part 1: Can a pill a day keep HIV away?
Part 2: A condom-free future?
Part 3: The controversy behind PrEP